Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2025-02-19 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
关于全资子公司完成工商设立登记并取得营业执照的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the establishment and business license registration of a wholly-owned subsidiary by the company. It includes details about the subsidiary's registration, capital, legal representative, and business scope. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is a corporate announcement about a capital investment and subsidiary formation, which fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2025-02-19 Chinese
关于子公司申请银行授信暨公司及关联方提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a subsidiary's application for bank credit and the provision of guarantees by the company and related parties. It includes details about the credit amount, guarantee terms, decision-making and approval procedures by the board and supervisory committee, and the impact on the company. There are no financial statements or detailed financial performance data presented, nor is this a transcript, report, or presentation. The document is a formal disclosure of a financing-related transaction and guarantee arrangement, which fits the category of Capital/Financing Update (CAP). The document length is about 3,134 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2025-01-23 Chinese
中信证券股份有限公司关于北京康乐卫士生物技术股份有限公司关联方为公司全资子公司增资协议项下回购义务提供担保事项的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding a guarantee provided by related parties for a capital increase agreement involving a wholly-owned subsidiary of Beijing Kangle Weishi Biotechnology Co., Ltd. It includes legal references, descriptions of the guarantee agreements, involved parties, and the approval process by the company's board and independent directors. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal verification or audit opinion related to a specific guarantee transaction. It does not contain financial statements or earnings data, nor is it a simple announcement or certification. Given the nature of the document as a verification opinion by the sponsor institution on a guarantee matter, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles or verification opinions related to regulatory or internal compliance matters. Q1 2025
2025-01-23 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management officer, specifically the Chief Capital Officer, including details about the nomination, approval by the board, and compliance with relevant laws and company regulations. It does not contain financial data, audit information, or report content. The document is clearly about management changes and appointments.
2025-01-23 Chinese
中信证券股份有限公司关于北京康乐卫士生物技术股份有限公司子公司申请银行授信并接受公司及关联方担保事项的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed opinion and verification report from a sponsoring institution (中信证券股份有限公司) regarding a subsidiary's application for bank credit and the acceptance of guarantees by the company and related parties. It references regulatory rules and internal approval procedures, including board and independent director meetings. The document does not contain financial statements or results but is a formal verification and opinion on a financing-related transaction. It is not an announcement of a report publication, nor is it a full financial report or earnings release. The content fits best with a Capital/Financing Update (CAP) as it concerns bank credit application and guarantees, which are financing activities.
2025-01-23 Chinese
第五届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fifth meeting of the fifth board of directors of Beijing Kangle Weishi Biotechnology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and decisions on financing, investment, management appointments, and internal management adjustments. The content focuses on board meeting decisions and management changes rather than financial results or audit information. It also references related announcements on the stock exchange platform but does not contain financial statements or earnings data. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3156 characters, which is consistent with a detailed board meeting resolution announcement rather than a full report or brief notice.
2025-01-23 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.